Novonix (NVX) Total Current Liabilities (2020 - 2025)

Novonix (NVX) has 6 years of Total Current Liabilities data on file, last reported at $83.6 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 80.7% year-over-year to $83.6 million; the trailing twelve-month figure through Dec 2025 stood at $83.6 million (up 80.7% YoY), and the FY2025 full-year result was $83.6 million, up 80.7% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $83.6 million, up from $46.2 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $83.6 million in Q4 2025 and bottomed at $4.1 million in Q2 2021.
• The 5-year median for Total Current Liabilities is $22.9 million (2022), against an average of $31.3 million.
• The widest annual swing landed in 2021, when Total Current Liabilities gained 3.41%; it then soared 340.17% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $4.1 million in 2021, then jumped by 105.3% to $8.5 million in 2022, then jumped by 340.17% to $37.3 million in 2023, then increased by 24.1% to $46.2 million in 2024, then soared by 80.7% to $83.6 million in 2025.
• The last three Total Current Liabilities figures came in at $83.6 million (Q4 2025), $46.2 million (Q4 2024), and $37.3 million (Q4 2023), per Business Quant data.

Peer Comparison